TY  - GEN
AU  - Yahata,Hideaki
AU  - Kobayashi,Hiroaki
AU  - Sonoda,Kenzo
AU  - Shimokawa,Mototsugu
AU  - Ohgami,Tatsuhiro
AU  - Saito,Toshiaki
AU  - Ogawa,Shinji
AU  - Sakai,Kunihiro
AU  - Ichinoe,Akimasa
AU  - Ueoka,Yousuke
AU  - Hasuo,Yasuyuki
AU  - Nishida,Makoto
AU  - Masuda,Satohiro
AU  - Kato,Kiyoko
TI  - Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin
SN  - 1437-7772
PY  - 2017///0111
KW  - Adult
KW  - Aged
KW  - Antiemetics
KW  - therapeutic use
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Aprepitant
KW  - Carboplatin
KW  - administration & dosage
KW  - Dexamethasone
KW  - Double-Blind Method
KW  - Drug Hypersensitivity
KW  - etiology
KW  - Drug Therapy, Combination
KW  - Female
KW  - Genital Neoplasms, Female
KW  - drug therapy
KW  - Humans
KW  - Middle Aged
KW  - Morpholines
KW  - Nausea
KW  - chemically induced
KW  - Paclitaxel
KW  - Remission Induction
KW  - Serotonin 5-HT3 Receptor Antagonists
KW  - Vomiting
KW  - Young Adult
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1007/s10147-015-0928-y
ER  -